Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Oye

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Annals of Internal Medicine|February 1, 1995
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatmentsW A Knaus, F E Harrell, J Lynn, et al.
Clinical Pharmacology and Therapeutics|February 17, 2012
Adaptive licensing: taking the next step in the evolution of drug approvalH-G Eichler, K Oye, L G Baird, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patientsH-G Eichler, L G Baird, R Barker, et al.
Physical Review Letters|July 21, 2011
Search for a heavy particle decaying into an electron and a muon with the ATLAS detector in sqrt[s] = 7 TeV pp collisions at the LHCG Aad, B Abbott, J Abdallah, et al.
Physical Review Letters|January 15, 2011
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHCG Aad, B Abbott, J Abdallah, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Annals of Internal Medicine|February 1, 1995
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatmentsW A Knaus, F E Harrell, J Lynn, et al.
Clinical Pharmacology and Therapeutics|February 17, 2012
Adaptive licensing: taking the next step in the evolution of drug approvalH-G Eichler, K Oye, L G Baird, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patientsH-G Eichler, L G Baird, R Barker, et al.
Physical Review Letters|July 21, 2011
Search for a heavy particle decaying into an electron and a muon with the ATLAS detector in sqrt[s] = 7 TeV pp collisions at the LHCG Aad, B Abbott, J Abdallah, et al.
Physical Review Letters|January 15, 2011
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHCG Aad, B Abbott, J Abdallah, et al.
Pageof 6